Box 4.6 Flavone-8-acetic acid (FAA) reduces thrombosis
Flavone-8-acetic acid (FAA) is a non-cytotoxic drug that has antitumor activity in mice. It has also been
found that FAA inhibits human platelet aggregation by blocking platelet surface receptor GPIbα binding
to von Willebrand factor, a large plasma protein. An in vivo study using a porcine animal model was
conducted to determine the effect of FAA on platelet aggregation (thrombosis) (Mruk et al., 2000). Pigs
were randomly assigned either to a treatment group that received an FAA bolus followed by continuous
infusion or to a control group that was administered placebo (saline solution). Balloon angioplasty was
performed for the carotid artery of all 20 pigs. Platelet deposition occurred in deeply injured arterial
regions that underwent dilatation. The mean deposited platelet concentration for the treated group was
(13 ± 3) × 10
6
cells/cm
2
, and for the control group was (165 ± 51) × 10
6
cells/cm
2
. The individual
values are listed in the following:
treated group: 5.5, 6.5, 8, 8, 9.5, 11.5, 14.5, 15, 15, and 33 × 10
6
/cm
2
, n
1
= 10,
control group: 10, 17, 60, 85, 90, 170, 240, 250, and 450 × 10
6
/cm
2
, n
2
=9.
To reduce the large variability in platelet deposition amounts, the data are transformed by taking the
natural logarithm. We want to determine if FAA has an effect on platelet deposition. The variances of the
log-transformed data of both groups differ by a factor of 6. We perform the t test for unequal variances
using the ttest2 function:
44
x1 = [5.5 6.5 8 8 9.5 11.5 14.5 15 15 33]*1e6;
44
x2 = [10 17 60 85 90 170 240 250 450]*1e6;
44
[h, p] = ttest2(log(x1), log(x2), 0.05, ‘both’, ‘unequal’)
h=
1
p=
8.5285e-004
Thus, the log of the amount of platelet deposition (thrombosis) in the porcine carotid artery during
FAA administration is significantly different from that observed in the absence of FAA dosing.
Fibrinogen deposition for both groups was also measured, and was (40 ± 8) × 10
12
molecules/cm
2
for the treated group and (140 ± 69) × 10
12
molecules/cm
2
for the control group.
The individual values are listed in the following:
treated group: 14, 16, 19, 22, 37, 39, 41, 50, 65, and 96 × 10
12
/cm
2
, n
1
= 10,
control group: 19, 20, 37, 38, 70, 120, 125, 200, and 700 × 10
12
/cm
2
, n
2
=9.
To reduce the large variability in fibrinogen deposition amounts, the data are transformed by taking
the natural logarithm:
44
x1 = [14 16 19 22 37 39 41 50 65 95]*1e12;
44
x2 = [19 20 37 38 70 120 125 200 700]*1e12;
44
[h, p] = ttest2(log(x1), log(x2), 0.05, ‘both’, ‘unequal’)
h=
0
p=
0.0883
Since p > 0.05, we conclude that the log of the amount of fibrinogen deposition in the porcine
carotid artery during FAA administration is not significantly different from that observed in the absence
of FAA dosing. These results indicate that FAA interferes with platelet binding to the injured vessel wall
but does not affect coagulation.
252
Hypothesis testing